1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of SORCS2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SORCS2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SORCS2 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SORCS2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SORCS2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SORCS2 mRNA CTD PMID:26377647 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Sorcs2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of SORCS2 mRNA CTD PMID:25172293 3,7-dihydropurine-6-thione increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Mercaptopurine results in increased expression of SORCS2 mRNA CTD PMID:23358152 3-chloropropane-1,2-diol increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of SORCS2 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of SORCS2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SORCS2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of SORCS2 mRNA CTD PMID:25825206 acrylamide decreases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of SORCS2 mRNA CTD PMID:28959563 acrylamide increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of SORCS2 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO SORCS2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SORCS2 mRNA CTD PMID:22100608 and PMID:32234424 aflatoxin B1 affects methylation ISO SORCS2 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of SORCS2 intron CTD PMID:30157460 aflatoxin B1 increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of SORCS2 mRNA CTD PMID:23630614 Aflatoxin B2 alpha increases methylation ISO SORCS2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SORCS2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO SORCS2 (Homo sapiens) 6480464 Tretinoin results in increased expression of SORCS2 mRNA CTD PMID:23724009 aristolochic acid A decreases expression ISO SORCS2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SORCS2 mRNA CTD PMID:33212167 arsane affects methylation ISO SORCS2 (Homo sapiens) 6480464 Arsenic affects the methylation of SORCS2 gene CTD PMID:25304211 arsenic atom affects methylation ISO SORCS2 (Homo sapiens) 6480464 Arsenic affects the methylation of SORCS2 gene CTD PMID:25304211 atrazine affects methylation ISO Sorcs2 (Rattus norvegicus) 6480464 Atrazine affects the methylation of SORCS2 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO SORCS2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SORCS2 mRNA CTD PMID:21871943 benzo[a]pyrene affects methylation ISO SORCS2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SORCS2 intron and Benzo(a)pyrene affects the methylation of SORCS2 promoter CTD PMID:27901495 and PMID:30157460 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SORCS2 mRNA CTD PMID:20713471 and PMID:22228805 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of SORCS2 mRNA CTD PMID:26377693 benzo[e]pyrene affects methylation ISO SORCS2 (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of SORCS2 intron CTD PMID:30157460 benzo[e]pyrene increases methylation ISO SORCS2 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SORCS2 exon CTD PMID:30157460 bisphenol A affects expression ISO Sorcs2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SORCS2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SORCS2 gene CTD PMID:31601247 bisphenol A decreases methylation ISO SORCS2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SORCS2 gene CTD PMID:31601247 bisphenol A increases methylation ISO Sorcs2 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of SORCS2 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SORCS2 mRNA CTD PMID:25594700 and PMID:35479511 Brodifacoum increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of SORCS2 protein CTD PMID:28903499 butane-2,3-dione decreases expression ISO SORCS2 (Homo sapiens) 6480464 Diacetyl results in decreased expression of SORCS2 mRNA CTD PMID:30710127 cantharidin decreases expression EXP 6480464 Cantharidin results in decreased expression of SORCS2 mRNA CTD PMID:36907384 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO SORCS2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SORCS2 gene] CTD PMID:28238834 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SORCS2 gene CTD PMID:20938992 cyclosporin A decreases methylation ISO SORCS2 (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of SORCS2 promoter CTD PMID:27989131 decabromodiphenyl ether multiple interactions ISO Sorcs2 (Rattus norvegicus) 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of SORCS2 mRNA CTD PMID:32207525 dorsomorphin multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects methylation ISO Sorcs2 (Rattus norvegicus) 6480464 Doxorubicin affects the methylation of SORCS2 gene CTD PMID:28962528 endosulfan increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SORCS2 mRNA CTD PMID:29391264 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SORCS2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO SORCS2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of SORCS2 mRNA CTD PMID:23649840 fenvalerate increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 fenvalerate results in increased expression of SORCS2 mRNA CTD PMID:30307764 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of SORCS2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO SORCS2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of SORCS2 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SORCS2 gene CTD PMID:31601247 furan increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 furan results in increased expression of SORCS2 mRNA CTD PMID:27387713 genistein decreases expression EXP 6480464 Genistein results in decreased expression of SORCS2 mRNA CTD PMID:32186404 gentamycin decreases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of SORCS2 mRNA CTD PMID:33387578 glyphosate affects methylation ISO Sorcs2 (Rattus norvegicus) 6480464 Glyphosate affects the methylation of SORCS2 gene CTD PMID:35440735 hydrogen peroxide affects expression ISO SORCS2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SORCS2 mRNA CTD PMID:20044591 iron dichloride decreases expression ISO SORCS2 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of SORCS2 mRNA CTD PMID:35984750 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of SORCS2 mRNA CTD PMID:20003209 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SORCS2 gene CTD PMID:20938992 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased methylation of SORCS2 intron CTD PMID:33445541 lead(0) affects expression ISO SORCS2 (Homo sapiens) 6480464 Lead affects the expression of SORCS2 mRNA CTD PMID:28903495 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased methylation of SORCS2 intron CTD PMID:33445541 manganese(II) chloride increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of SORCS2 mRNA CTD PMID:28801915 mercaptopurine increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Mercaptopurine results in increased expression of SORCS2 mRNA CTD PMID:23358152 methapyrilene affects methylation ISO SORCS2 (Homo sapiens) 6480464 Methapyrilene affects the methylation of SORCS2 intron CTD PMID:30157460 methapyrilene increases methylation ISO SORCS2 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SORCS2 exon CTD PMID:30157460 methoxychlor affects methylation ISO Sorcs2 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of SORCS2 gene CTD PMID:35440735 methyl methanesulfonate increases expression ISO SORCS2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of SORCS2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO SORCS2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SORCS2 mRNA CTD PMID:28001369 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SORCS2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SORCS2 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS2 mRNA CTD PMID:27188386 panobinostat decreases expression ISO SORCS2 (Homo sapiens) 6480464 panobinostat results in decreased expression of SORCS2 mRNA CTD PMID:26272509 paraquat decreases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Paraquat results in decreased expression of SORCS2 mRNA CTD PMID:32680482 pentane-2,3-dione decreases expression ISO SORCS2 (Homo sapiens) 6480464 2 and 3-pentanedione results in decreased expression of SORCS2 mRNA CTD PMID:30710127 phenylmercury acetate decreases expression ISO SORCS2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SORCS2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS2 mRNA CTD PMID:27188386 purine-6-thiol increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Mercaptopurine results in increased expression of SORCS2 mRNA CTD PMID:23358152 SB 431542 multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sulforaphane decreases expression ISO SORCS2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of SORCS2 mRNA CTD PMID:31838189 sunitinib decreases expression ISO SORCS2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SORCS2 mRNA CTD PMID:31533062 testosterone increases expression ISO SORCS2 (Homo sapiens) 6480464 Testosterone results in increased expression of SORCS2 mRNA CTD PMID:33359661 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SORCS2 mRNA CTD PMID:23557971 and PMID:27760801 trichloroethene increases expression ISO Sorcs2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of SORCS2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO SORCS2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SORCS2 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS2 mRNA CTD PMID:27188386 triclosan increases expression ISO SORCS2 (Homo sapiens) 6480464 Triclosan results in increased expression of SORCS2 mRNA CTD PMID:30510588 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of SORCS2 mRNA CTD PMID:30912803 urethane decreases expression ISO SORCS2 (Homo sapiens) 6480464 Urethane results in decreased expression of SORCS2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO SORCS2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SORCS2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO SORCS2 (Homo sapiens) 6480464 Valproic Acid affects the expression of SORCS2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS2 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO SORCS2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS2 mRNA CTD PMID:27188386